Introduction:Basic information about CAS 132112-35-7|Ropivacaine hydrochloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Ropivacaine hydrochloride |
|---|
| CAS Number | 132112-35-7 | Molecular Weight | 328.88 |
|---|
| Density | 1.0±0.1 g/cm3 | Boiling Point | 410.2±45.0 °C at 760 mmHg |
|---|
| Molecular Formula | C17H29ClN2O2 | Melting Point | 267-269ºC |
|---|
| MSDS | ChineseUSA | Flash Point | 201.9±28.7 °C |
|---|
| Symbol | GHS05 | Signal Word | Danger |
|---|
Names
| Name | (S)-ropivacaine hydrochloride hydrate |
|---|
| Synonym | More Synonyms |
|---|
Ropivacaine hydrochloride BiologicalActivity
| Description | Ropivacaine HCl is an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly.Target: Sodium ChannelRopivacaine is a new long-acting local anesthetic, with vasoconstrictive properties. Ropivacaine given epidurally provided adequate sensory anesthesia and motor block for transurethral surgery. Addition of epinephrine did not provide any significant prolongation of the sensory or motor block, nor any influence upon the sympathetic block [1]. Ropivacaine was metabolized to 2',6'-pipecoloxylidide (PPX), 3'-hydroxyropivacaine (3'-OH Rop), and 4'-hydroxyropivacaine (4'-OH Rop) by hepatic microsomes from human and rat. Ropivacaine N-dealkylation and 3'-hydroxylation activities correlated well with the level of CYP3A4 and 1A2 in human hepatic microsomes, respectively [2]. |
|---|
| Related Catalog | Signaling Pathways >>Membrane Transporter/Ion Channel >>Sodium ChannelResearch Areas >>Neurological Disease |
|---|
| References | [1]. Cederholm, I., S. Anskar, and M. Bengtsson, Sensory, motor, and sympathetic block during epidural analgesia with 0.5% and 0.75% ropivacaine with and without epinephrine. Reg Anesth, 1994. 19(1): p. 18-33. [2]. Oda, Y., et al., Metabolism of a new local anesthetic, ropivacaine, by human hepatic cytochrome P450. Anesthesiology, 1995. 82(1): p. 214-20. |
|---|
Chemical & Physical Properties
| Density | 1.0±0.1 g/cm3 |
|---|
| Boiling Point | 410.2±45.0 °C at 760 mmHg |
|---|
| Melting Point | 267-269ºC |
|---|
| Molecular Formula | C17H29ClN2O2 |
|---|
| Molecular Weight | 328.88 |
|---|
| Flash Point | 201.9±28.7 °C |
|---|
| PSA | 41.57000 |
|---|
| LogP | 3.11 |
|---|
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
|---|
| Index of Refraction | 1.552 |
|---|
| InChIKey | VSHFRHVKMYGBJL-CKUXDGONSA-N |
|---|
| SMILES | CCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl.O |
|---|
| Storage condition | Refrigerator |
|---|
Safety Information
| Symbol | GHS05 |
|---|
| Signal Word | Danger |
|---|
| Hazard Statements | H318 |
|---|
| Precautionary Statements | P280-P305 + P351 + P338 + P310 |
|---|
| Hazard Codes | T: Toxic; |
|---|
| Risk Phrases | R26/27/28 |
|---|
| Safety Phrases | 22-36/37/39-45 |
|---|
| RIDADR | UN 2811 6.1 / PGIII |
|---|
| HS Code | 2933399090 |
|---|
Customs
| HS Code | 2933399090 |
|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Synonyms
| (S)-ROPIVACAINE HCL |
| (2S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide |
| (S)-ROPIVACAINE HYDROCHLORIDE |
| (S)ROPIVACAINE HYDROCHLORIDE |
| (S)-ROPIVACAINEHYDROCHLORIDE |
| UNII-V910P86109 |
| (-)-1-propyl-2',6'-dimethyl-2-piperidylcarboxyanilide |
| Ropivacaine |
| Ropivacaine hydrochloride Monohydrate |
| (S)ROPIVACAINE HY DROCHLORIDE |
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)-, hydrochloride, hydrate (1:1:1) |
| S-ROPIVACAINE HCL |
| Ropivacaine (hydrochloride Monohydrate) |
| (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide |
| (+-)-ropivacaine hydrochloride |
| (S)-ROPIVACAINEHCL |
| (S)-(-)-1-propyl-2',6'-pipecoloxylidide |
| S-ROPIVACAINEHCL |
| 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-propyl-, (2S)- |
| Ropivacainehydrochloride |
| Ropivacaine hydrochloride |
| (S)-(-)-1-propyl-2',6'-pipecoloxylidine hydrochloride monohydrate |
| l-N-n-Propylpipecolic acid-2,6-xylidide |
| (-)-1-Propyl-2',6'-pipecoloxylidide |
| UNII-7IO5LYA57N |
| (S)-ropivacaine hydrochloride hydrate |
| (S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinecarboxamide |
| ropivacaine hydrochloride hydrate |
| Ropivacaine HCl.H2O |
| Ropivacaine HCl |
| S-ROPIVACAINE HYDROCHLORIDE |
| (2S)-N-(2,6-Dimethylphenyl)-1-propyl-2-piperidinecarboxamide hydrochloride hydrate |
| (2S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride hydrate |
| MFCD02102164 |